[
  {
    "ts": "2025-12-05T16:28:46+00:00",
    "headline": "Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says",
    "summary": "Edwards Lifesciences (EW) reiterated its long-term business outlook on a growing portfolio of struct",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-apos-long-term-162846099.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "bbbb8e09-e98b-3686-8153-f9cd4614e168",
      "content": {
        "id": "bbbb8e09-e98b-3686-8153-f9cd4614e168",
        "contentType": "STORY",
        "title": "Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says",
        "description": "",
        "summary": "Edwards Lifesciences (EW) reiterated its long-term business outlook on a growing portfolio of struct",
        "pubDate": "2025-12-05T16:28:46Z",
        "displayTime": "2025-12-05T16:28:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-apos-long-term-162846099.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-apos-long-term-162846099.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-05T19:09:53+00:00",
    "headline": "Edwards Lifesciences (EW): Reassessing Valuation After Upbeat 2025–2026 Outlook and TAVR Growth Signals",
    "summary": "Edwards Lifesciences (EW) used its annual investor day to lift its 2025 revenue outlook and lay out fresh 2026 guidance, reinforcing the case that its TAVR franchise is still doing the heavy lifting. See our latest analysis for Edwards Lifesciences. The guidance bump comes after a strong third quarter and upbeat TAVR data, and the market has taken notice, with an 18.17% year to date share price return and a 1 year total shareholder return of 18.43%, signaling that momentum is building...",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-reassessing-valuation-190953322.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0f39a0b1-3fba-3b12-8f4c-6fb9af4d9ebf",
      "content": {
        "id": "0f39a0b1-3fba-3b12-8f4c-6fb9af4d9ebf",
        "contentType": "STORY",
        "title": "Edwards Lifesciences (EW): Reassessing Valuation After Upbeat 2025–2026 Outlook and TAVR Growth Signals",
        "description": "",
        "summary": "Edwards Lifesciences (EW) used its annual investor day to lift its 2025 revenue outlook and lay out fresh 2026 guidance, reinforcing the case that its TAVR franchise is still doing the heavy lifting. See our latest analysis for Edwards Lifesciences. The guidance bump comes after a strong third quarter and upbeat TAVR data, and the market has taken notice, with an 18.17% year to date share price return and a 1 year total shareholder return of 18.43%, signaling that momentum is building...",
        "pubDate": "2025-12-05T19:09:53Z",
        "displayTime": "2025-12-05T19:09:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9u7koo0rZkPGzBeI1l4rsQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5J1KBMD97NZX1sIZ71qfPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-reassessing-valuation-190953322.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-reassessing-valuation-190953322.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-05T20:56:56+00:00",
    "headline": "Sector Update: Health Care Stocks Lower Late Afternoon",
    "summary": "Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-lower-205656620.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "f2587c0b-b89f-3e1a-84b3-202b710bb4ed",
      "content": {
        "id": "f2587c0b-b89f-3e1a-84b3-202b710bb4ed",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Lower Late Afternoon",
        "description": "",
        "summary": "Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and",
        "pubDate": "2025-12-05T20:56:56Z",
        "displayTime": "2025-12-05T20:56:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-lower-205656620.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-lower-205656620.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            },
            {
              "symbol": "CNMD"
            },
            {
              "symbol": "RDY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "HUM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-05T23:11:57+00:00",
    "headline": "Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative?",
    "summary": "Edwards Lifesciences’ recent Investor Day outlined upgraded 2025 revenue growth expectations of about 9%–10% and introduced 2026 adjusted EPS guidance of US$2.80–US$2.95, alongside anticipated constant-currency sales growth of 8%–10%. The company underscored its transcatheter aortic valve replacement franchise as a central growth engine, reinforcing confidence in long-term opportunities despite tariff headwinds, competitive pressures, and acquisition-related earnings dilution risks. We’ll...",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-upgraded-2025-231157335.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1458550b-54b5-3e4f-ac60-2860b1623d99",
      "content": {
        "id": "1458550b-54b5-3e4f-ac60-2860b1623d99",
        "contentType": "STORY",
        "title": "Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative?",
        "description": "",
        "summary": "Edwards Lifesciences’ recent Investor Day outlined upgraded 2025 revenue growth expectations of about 9%–10% and introduced 2026 adjusted EPS guidance of US$2.80–US$2.95, alongside anticipated constant-currency sales growth of 8%–10%. The company underscored its transcatheter aortic valve replacement franchise as a central growth engine, reinforcing confidence in long-term opportunities despite tariff headwinds, competitive pressures, and acquisition-related earnings dilution risks. We’ll...",
        "pubDate": "2025-12-05T23:11:57Z",
        "displayTime": "2025-12-05T23:11:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9u7koo0rZkPGzBeI1l4rsQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5J1KBMD97NZX1sIZ71qfPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-upgraded-2025-231157335.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-upgraded-2025-231157335.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]